We are live on ! Find out more
ETCM

Evolutionary Tree Capital Management Portfolio holdings

AUM $53.2M
1-Year Est. Return 13.56%
This Fund
S&P 500
This Quarter Est. Return
+0.88%
1 Year Est. Return
+13.56%
3 Year Est. Return
+100.03%
5 Year Est. Return
+61.7%
10 Year Est. Return
–
AUM
$225M
AUM Growth
+$8.52M
Cap. Flow
+$17.9M
Cap. Flow %
7.94%
Top 10 Hldgs %
44.69%
Holding
47
New
6
Increased
27
Reduced
7
Closed
1

Top Buys

Rank Stock Value
1
CFLT
Confluent
CFLT
+$5.53M
2
DOCN icon
DigitalOcean
DOCN
+$4.84M
3
XYZ
Block Inc
XYZ
+$4.2M
4
SNAP icon
Snap
SNAP
+$3.41M
5
NCNO icon
nCino
NCNO
+$1.84M

Top Sells

Rank Stock Value
1
TTD icon
Trade Desk
TTD
+$5.93M
2
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$5.06M
3
SE icon
Sea Limited
SE
+$4.22M
4
ZS icon
Zscaler
ZS
+$1.83M
5
ESTC icon
Elastic
ESTC
+$1.81M

Sector Composition

Rank Sector Weight
1 Technology 46.35%
2 Consumer Discretionary 17.34%
3 Healthcare 17.29%
4 Communication Services 14.59%
5 Industrials 1.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
XYZ
26
Block Inc
XYZ
$47.2B
$3.92M 1.74%
+16,343
New +$4.2M
BEAM icon
27
Beam Therapeutics
BEAM
$2.71B
$3.86M 1.71%
44,390
+358
+0.8% +$36K
ASND icon
28
Ascendis Pharma A/S
ASND
$16.5B
$3.71M 1.64%
23,242
+5,872
+34% +$804K
PYPL icon
29
PayPal
PYPL
$50.1B
$3.63M 1.61%
13,950
+1,669
+14% +$474K
SNAP icon
30
Snap
SNAP
$7.67B
$3.49M 1.55%
+47,195
New +$3.41M
DXCM icon
31
DexCom
DXCM
$29.2B
$3.43M 1.52%
25,080
-1,984
-7% -$250K
DOCU
32
DocuSign
DOCU
$9.99B
$3.32M 1.47%
12,893
+1,501
+13% +$432K
DMTK
33
DELISTED
DermTech, Inc. Common Stock
DMTK
$2.87M 1.27%
89,418
+10,839
+14% +$381K
ZM icon
34
Zoom
ZM
$26.7B
$2.81M 1.25%
10,734
+3,053
+40% +$1.03M
U icon
35
Unity
U
$13B
$2.28M 1.01%
18,064
+2,130
+13% +$252K
DRNA
36
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$1.87M 0.83%
92,898
-48,426
-34% -$1.34M
NYXH
37
Nyxoah
NYXH
$156M
$1.13M 0.5%
+38,490
New +$1.22M
MELI icon
38
Mercado Libre
MELI
$92.9B
$469K 0.21%
279
-285
-51% -$494K
V icon
39
Visa
V
$686B
$343K 0.15%
1,540
– –
GOOGL icon
40
Alphabet (Google) Class A
GOOGL
$4.3T
$337K 0.15%
2,520
– –
TTD icon
41
Trade Desk
TTD
$8.76B
$334K 0.15%
4,750
-76,690
-94% -$5.93M
ADBE icon
42
Adobe
ADBE
$93.3B
$325K 0.14%
565
– –
CRM icon
43
Salesforce
CRM
$142B
$320K 0.14%
1,180
– –
SPOT icon
44
Spotify
SPOT
$101B
$261K 0.12%
1,158
– –
META icon
45
Meta Platforms (Facebook)
META
$1.64T
$232K 0.1%
685
– –
PAGS icon
46
PagSeguro Digital
PAGS
$2.6B
$214K 0.1%
+4,132
New +$232K
ALNY icon
47
Alnylam Pharmaceuticals
ALNY
$36.4B
– –
-29,870
Closed -$5.06M
1
2

Similar funds

WEO
William E. Oberndorf $53.3M AUM 10.89% 1-Year Est. Return
NCM
Notable Capital Management Menlo Park, California $53.4M AUM 10.98% 1-Year Est. Return
TP
Toronado Partners San Francisco, California $53M AUM 13.38% 1-Year Est. Return
GMEI
Global Media & Entertainment Investments Nassau, Bahamas $53M AUM 0% 1-Year Est. Return
FRGX
First Reserve GP XIII Stamford, Connecticut $52.9M AUM 17.37% 1-Year Est. Return
BCM
BIOS Capital Management Fort Worth, Texas $52.9M AUM 30.51% 1-Year Est. Return
ICM
Irth Capital Management New York $52.8M AUM 21.11% 1-Year Est. Return
SCP
SymBiosis Capital Partners Bentonville, Arkansas $52.8M AUM

Evolutionary Tree Capital Management's Q3 2021 Portfolio in Review

As of Q3 2021, Evolutionary Tree Capital Management held 47 positions worth $225M, up 3.9% from $217M the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Evolutionary Tree Capital Management deployed $17.9M of net new capital in Q3 2021, opening 6 new positions and adding to 27 existing holdings. Its largest new stake was Confluent: 106,505 shares worth $6.35M.

By sector, the portfolio is most concentrated in Technology at 46% of assets, up from 36% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Trade Desk, an estimated $5.93M trimmed.

  • Evolutionary Tree Capital Management's largest Q3 2021 buy was Confluent: 106,505 shares worth $6.35M.
  • Evolutionary Tree Capital Management added most to nCino in Q3 2021, an estimated $1.84M increase.
  • Evolutionary Tree Capital Management's biggest Q3 2021 reduction was Trade Desk, cutting an estimated $5.93M.
  • Evolutionary Tree Capital Management fully exited Alnylam Pharmaceuticals in Q3 2021, selling an estimated $5.06M.
  • Evolutionary Tree Capital Management's ten largest holdings make up 45% of its $225M portfolio in Q3 2021.
  • Evolutionary Tree Capital Management opened 6 new positions and closed 1 in Q3 2021.
  • Evolutionary Tree Capital Management's portfolio value rose 3.9% quarter-over-quarter to $225M.

Based on Evolutionary Tree Capital Management's 13F filing for Q3 2021, filed 12 Nov 2021.